According to filings with the U.S. Securities and Exchange Commission, Adial Pharmaceuticals is raising $3,998,582.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Cary Claiborne played a key role…
Charlottesville, VA – According to filings with the U.S. Securities and Exchange Commission, Adial Pharmaceuticals is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, William Stilley played a…
Charlottesville, VA – According to filings with the U.S. Securities and Exchange Commission, Adial Pharmaceuticals is raising $5,217,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, William Stilley played a…